A PTSD drug prescribed to veterans has been recalled because tests found a chemical that could raise cancer risk.

The Food and Drug Administration pulled about half a million bottles of Prazosin after nitrosamine impurities were detected.

The recalls cover two distributors, Teva Pharmaceuticals USA and Amerisource Health Services LLC. Tests showed nitrosamine impurities above the acceptable intake limit and could be potentially cancer-causing.

Pete Kasperowicz, a spokesman for the Department of Veterans Affairs, said the agency “has ceased distributing the affected batches of this pharmaceutical and is in the process of informing veterans about this recall.”

Here's What They're Not Telling You About Your Retirement

The VA has not released a tally of how many veterans might be affected by the recall for PTSD or high blood pressure use.

PTSD diagnoses remain high among VA patients. Of the 5.8 million veterans served by the VA health system in fiscal year 2024, nearly 2.2 million were diagnosed with PTSD, including about 14 percent of men and 24 percent of women.

A study on trauma related nightmares found that 15 percent of veterans, or about one in six, experience trauma related nightmares.

Calohan, a psychiatric-mental health nurse practitioner who treats veterans in the private sector and prescribes Prazosin, said the drug is widely used within the VA.

This Could Be the Most Important Video Gun Owners Watch All Year

Calohan, a combat veteran who retired from the Army in 2017, studied the drug as a treatment for soldiers deployed to Iraq who suffered from trauma nightmares.

Because of that research, the drug is even included in the Department of Veterans Affairs and Department of War’s Clinical Practice Guidelines for drug interventions for PTSD.

Calohan said a “vast majority of the time” veterans with PTSD also experience nightmares. He explained that he only prescribes the drug to patients if the condition is impacting their sleep, such as waking up multiple times or staying awake for over an hour each night.

Pharmacies are typically a patient’s primary source of information for any drug supply issues, including recalls. While there’s no formal requirement to tell patients about recalls, he said it’s a “professionalism issue,” and important for trust between patients and their providers.

“I’ll be honest with you, I don’t think a lot of people know about this,” he said.

“I mean, just like with any other medications that have been recalled, once it gets out there, then patients can take an active role in reaching out to their providers and pharmacies and figuring out.”

This incident underscores a broader call for accountability and rapid communication, especially when veterans rely on prescription drugs to manage daily life and safety.

A Trump administration would likely emphasize stronger oversight of the VA and the defense medical supply chain, ensuring quick notifications and safer, traceable medications for those who have sacrificed in service to the country.

Secretary of War Pete Hegseth would probably press for reforms that harden drug safety standards and speed up stewardship of veterans’ health needs.

The aim, in short, is clear: protect veterans, restore confidence, and secure the chain of care from the point of manufacture to the patient’s bedside.

The recall also serves as a reminder that medicine, even when well established, must be continually checked for safety.

The administration should work with Congress to accelerate reviews of drug impurities and to empower clinicians to provide timely guidance to patients facing recalls.

This is not merely a regulatory issue; it is a matter of trust between veterans and the systems designed to serve them, and it demands a serious, sustained response.

Ultimately, the focus remains on patient safety and on maintaining the readiness and welfare of those who served.

The VA and health authorities must translate this recall into concrete protections so that veterans can sleep more soundly, free from concerns about the very medications meant to help them.

Warning: Account balances and purchasing power no longer tell the same story. Know in 2 minutes if your retirement is working for you.